Browsing by Author Cohen, Geoff

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2015Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke TrialLindley, Richard; Blackwell, Lisa; Cohen, Geoff; Murray, Gordon; Sandercock, Peter A G; Wardlaw, Joanna; Whiteley, Will; Western Clinical School: Medicine (Westmead)Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial, Stroke, vol.46, 3, 2015,pp 746-756
2015Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third international stroke trial (IST-3): Secondary analysis of a randomised controlled trialLindley, Richard; Adami, Alessandro; Bradey, Nick; Cala, Lesley; Cohen, Geoff; et al, Various; Farrall, Andrew; Peeters, Andre; Sandercock, Peter; von Heijne, Anders; von Kummer, Rudiger; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third international stroke trial (IST-3): Secondary analysis of a randomised controlled trial, The Lancet Neurology, vol.14, 5, 2015,pp 485-496
2012The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialLindley, Richard; Cohen, Geoff; Czlonkowska, Anna; Dennis, Martin; et al, Various; Innes, Karen; Kobayashi, Adam; Krause, Martin; Murray, Gordon; Ricci, Stefano; Sandercock, Peter A G; Venables, Graham; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, The Lancet, vol.379, 9834, 2012,pp 2352-2363
2014Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality (Third International Stroke Trial)Lindley, Richard; Cohen, Geoff; Murray, Gordon D; Sandercock, Peter; Thompson, Douglas; Wardlaw, Joanna; Whiteley, Will; Western Clinical School: Medicine (Westmead)Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality (Third International Stroke Trial), Stroke, vol.45, 12, 2014,pp 3612-3617
2015Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc AnalysisLindley, Richard; Broderick, Joseph P; Cohen, Geoff; Khatri, Pooja; Sandercock, Peter; Tayama, Darren; Wardlaw, Joanna; Yeatts, Sharon; Western Clinical School: Medicine (Westmead)Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis, Stroke, vol.46, 8, 2015,pp 2325-2327
2016Effect of right insular involvement on death and functional outcome after acute ischemic stroke in the IST-3 trial (Third International Stroke Trial)Lindley, Richard; Cohen, Geoff; Hachinski, Vladimir; Sandercock, Peter; Sposato, Luciano; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Effect of right insular involvement on death and functional outcome after acute ischemic stroke in the IST-3 trial (Third International Stroke Trial), Stroke, vol.47, 12, 2016,pp 2959-2965
2014Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trialsLindley, Richard; Albers, Gregory; Blackwell, Lisa; Bluhmki, Erich; Brott, Thomas; Cohen, Geoff; Davis, Stephen; Donnan, Geoffrey; Emberson, Jonathan; et al, Various; Lees, Kennedy R; Lyden, Patrick; Western Clinical School: Medicine (Westmead)Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials, The Lancet, vol.384, 9958, 2014,pp 1929-1935
2016Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trialLindley, Richard; Berge, Eivind; Cohen, Geoff; et al, Various; Forbes, John; Isaksson, Eva; Lundstrom, Erik; Roaldsen, Melinda B; Rudberg, Ann-Sofie; Slot, Karsten Bruins; Smith, Joel; Western Clinical School: Medicine (Westmead)Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial, The Lancet Neurology, vol.15, 10, 2016,pp 1028-1034
2015Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic StrokeLindley, Richard; Berge, Eivind; Cohen, Geoff; Sandercock, Peter; Sandset, Else C; Wardlaw, Joanna; Whiteley, Will; Western Clinical School: Medicine (Westmead)Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke, Stroke, vol.46, 12, 2015,pp 3362-3369
2015Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic strokeLindley, Richard; Carpenter, Trevor; Chappell, Francesca; Cohen, Geoff; Kobayashi, Adam; Murray, Veronica; Parsons, Mark; Peeters, Andre; Sandercock, Peter A G; von Kummer, Rudiger; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke, International Journal of Stroke, vol.10, 6, 2015,pp 956-968
2012Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisLindley, Richard; Berge, Eivind; Cohen, Geoff; del Zoppo, Gregory; Murray, Veronica; Sandercock, Peter A G; Wardlaw, Joanna; Western Clinical School: Medicine (Westmead)Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, The Lancet, vol.379, 9834, 2012,pp 2364-2372
2014Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trialLindley, Richard; Cohen, Geoff; Murray, Gordon D; Sandercock, Peter A G; Thompson, Douglas; Wardlaw, Joanna; Whiteley, William; Western Clinical School: Medicine (Westmead)Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trial, Stroke, vol.45, 4, 2014,pp 1000-1006
2011Update on the third international stroke trial (IST- 3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruitedLindley, Richard; Buchanan, David; Cohen, Geoff; Czlonkowska, Anna; Dennis, Martin S.; et al, various; Innes, Karen; Kobayashi, Adam; Perry, David; Sandercock, Peter; Soosay, Vera; Venables, Graham; Wardlaw, J. M.; Whiteley, William; Western Clinical School: Medicine (Westmead)Update on the third international stroke trial (IST- 3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited, Trials, vol.12, 252, 2011,pp 1-9